CAM
GOSS icon

Close Asset Management’s Gossamer Bio GOSS Stock Holding History

Close Asset Management’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Hold
0
– – – 205
2022
Q3 		– Hold
0
– – – 190
2022
Q2 		– Sell
-72
Closed -$44.6K – 200
2022
Q1 		$65K Hold
72
– – ﹤0.01% 113
2021
Q4 		$65K Hold
72
– – ﹤0.01% 113
2021
Q3 		$72K Buy
+72
New +$53K ﹤0.01% 105

Other funds holding GOSS

State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Close Asset Management's GOSS Position: Q4 2022 in Review

Close Asset Management held its Gossamer Bio (GOSS) position steady in Q4 2022 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #205.

Close Asset Management first reported a position in GOSS in Q3 2021 and has held it in 3 quarters since. The position peaked at $72K in Q3 2021. 118 funds tracked by Wall St. Rank hold GOSS as of Q4 2022.

  • Close Asset Management held 0 shares of Gossamer Bio worth $0 as of Q4 2022.
  • Close Asset Management left its Gossamer Bio share count unchanged in Q4 2022.
  • Gossamer Bio made up ﹤0.01% of Close Asset Management's portfolio in Q4 2022, its #205 holding.
  • Close Asset Management first reported a position in Gossamer Bio in Q3 2021 and has held it in 3 quarters since.
  • Close Asset Management's Gossamer Bio position peaked at $72K in Q3 2021.
  • 118 funds tracked by Wall St. Rank held Gossamer Bio as of Q4 2022.

Based on Close Asset Management's 13F filing for Q4 2022, filed 27 Jan 2023.